Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Johannes H Proost"'
Autor:
Niels Westra, Johannes H Proost, Casper F M Franssen, Erik B Wilms, Marjolijn van Buren, Daan J Touw
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216801 (2019)
BackgroundVancomycin is frequently used in hemodialysis (HD) and in hemodiafiltration (HDF) patients and is usually administered in the last 30 or 60 minutes of a dialysis session. Vancomycin pharmacokinetics are not well described in HDF patients. T
Externí odkaz:
https://doaj.org/article/75862af80f3840deab874975b766f807
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177324 (2017)
Gentamicin shows large variations in half-life and volume of distribution (Vd) within and between individuals. Thus, monitoring and accurately predicting serum levels are required to optimize effectiveness and minimize toxicity. Currently, two popula
Externí odkaz:
https://doaj.org/article/0a7fd192afe7484fa0723f0930fd594c
Autor:
Michel Struys, Johannes H. Proost, Hugo Vereecke, K. van Amsterdam, Alain Kalmar, Sascha Meier, Allart M. Venema, Anthony Absalom, Thomas Scheeren, Laura N. Hannivoort, J. P. van den Berg
Publikováno v:
Journal of clinical monitoring and computing, 35. SPRINGER HEIDELBERG
JOURNAL OF CLINICAL MONITORING AND COMPUTING
Journal of Clinical Monitoring and Computing
JOURNAL OF CLINICAL MONITORING AND COMPUTING
Journal of Clinical Monitoring and Computing
This prospective study evaluates haemodynamic and electroencephalographic effects observed when administering four combinations of effect-site concentrations of propofol (CePROP) and remifentanil (CeREMI), all yielding a single predicted probability
Publikováno v:
The AAPS Journal
Aaps journal, 23(1):10. SPRINGER
AAPS JOURNAL
Aaps journal, 23(1):10. SPRINGER
AAPS JOURNAL
The relationship between the concentration of a drug and its pharmacological effect is often described by empirical mathematical models. We investigated the relationship between the steepness of the concentration–effect relationship and inter-indiv
Publikováno v:
Aaps journal, 22(2):25. SPRINGER
This article provides a dialogue covering an ongoing controversy on the use of clearance versus rate constant approaches for model parameterization when assessing pharmacokinetic (PK) data. It reflects the differences in opinions that can exist among
Autor:
Karl M. Weigand, Marola M.H. van Lipzig, Frans G. M. Russel, Sylvia Notenboom, Petra H.H. van den Broek, Geny M. M. Groothuis, Johannes H. Proost, Rick Greupink, Evita van de Steeg
Publikováno v:
European Journal of Pharmaceutical Sciences, 115, pp. 175-184
European Journal of Pharmaceutical Sciences, 115, 175-184. ELSEVIER SCIENCE BV
European Journal of Pharmaceutical Sciences, 115, 175-184
European Journal of Pharmaceutical Sciences, 115, 175-184. ELSEVIER SCIENCE BV
European Journal of Pharmaceutical Sciences, 115, 175-184
Drug-induced liver injury (DILI) is a common reason for drug withdrawal from the market. An important cause of DILI is drug-induced cholestasis. One of the major players involved in drug-induced cholestasis is the bile salt efflux pump (BSEP; ABCB11)
Autor:
Dirk-Jan van den Berg, Elizabeth C. M. de Lange, Pyry A. J. Välitalo, Margot W. Beukers, Johan G. C. van Hasselt, Walter Krauwinkel, An Vermeulen, Robin Hartman, Yumi Yamamoto, Meindert Danhof, Yin Cheong Wong, Dymphy Huntjens, Johannes H. Proost
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Drug development targeting the central nervous system (CNS) is challenging due to poor predictability of drug concentrations in various CNS compartments. We developed a generic physiologically based pharmacokinetic (PBPK) model for prediction of drug
Autor:
Willem van den Brink, Yin Cheong Wong, Meindert Danhof, Pyry A. J. Välitalo, Johannes H. Proost, Dymphy Huntjens, An Vermeulen, Elizabeth C. M. de Lange, William Couet, Walter Krauwinkel, Claire Dahyot-Fizelier, Dirk-Jan van den Berg, Robin Hartman, Vincent Aranzana-Climent, Sandrine Marchand, Suruchi Bakshi, Yumi Yamamoto, Johan G. C. van Hasselt
Publikováno v:
Pharmaceutical Research, 34(2), 333-351. SPRINGER/PLENUM PUBLISHERS
Pharmaceutical Research
Pharmaceutical Research, 34(2), 333–351
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2017, 34 (2), pp.333-351. ⟨10.1007/s11095-016-2065-3⟩
Pharmaceutical Research
Pharmaceutical Research, 34(2), 333–351
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2017, 34 (2), pp.333-351. ⟨10.1007/s11095-016-2065-3⟩
Purpose Predicting target site drug concentration in the brain is of key importance for the successful development of drugs acting on the central nervous system. We propose a generic mathematical model to describe the pharmacokinetics in brain compar
Autor:
Hugo Vereecke, Anthony Absalom, Johann Wietasch, Douglas J. Eleveld, Johannes H. Proost, J. P. van den Berg, Michel Struys
Publikováno v:
British Journal of Anaesthesia. 118:44-57
This review describes the basics of pharmacokinetic and pharmacodynamic drug interactions and methodological points of particular interest when designing drug interaction studies. It also provides an overview of the available literature concerning in
Autor:
Daan J Touw, Marjolijn van Buren, Erik B Wilms, Niels Westra, Casper F. M. Franssen, Johannes H. Proost
Publikováno v:
PLoS ONE, 14(5):e0216801. PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 14, Iss 5, p e0216801 (2019)
PLoS ONE
PLoS ONE, Vol 14, Iss 5, p e0216801 (2019)
PLoS ONE
BackgroundVancomycin is frequently used in hemodialysis (HD) and in hemodiafiltration (HDF) patients and is usually administered in the last 30 or 60 minutes of a dialysis session. Vancomycin pharmacokinetics are not well described in HDF patients. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b1459ba8f1205d63648c2363307a761
https://research.rug.nl/en/publications/396f3dea-4566-426c-be44-ad4c51665d07
https://research.rug.nl/en/publications/396f3dea-4566-426c-be44-ad4c51665d07